Cielo Review

Cielo: a stripped-down, price-first compounded GLP-1 platform

Cielo is one of the rare telehealth brands that does exactly one thing and refuses to do anything else. There is no TRT upsell, no hair-loss bolt-on, no anxiety or sleep add-on, and no brand-name Wegovy or Zepbound. It sells compounded semaglutide and compounded tirzepatide, full stop. If your only goal is to start a GLP-1 at the lowest plausible monthly cost and you don't need the program to be anything more than that, Cielo is squarely aimed at you. If you want hand-holding, brand-name medication, or visible third-party accreditation, you'll want to read the cautions below before you commit.

How the pricing actually works

Cielo's whole pitch is built on a flat-rate model: the same price applies at every dose, so your monthly cost doesn't climb as you titrate up. That's genuinely useful, because at many competitors the bill quietly rises each time your clinician increases your dose. Here the math is fixed from the start.

The cheapest number — $115 a month for semaglutide — is the per-month rate when you commit to a three-month bundle. That lands at or below the category median of $170, which is why Cielo ranks as one of the lowest-priced compounded GLP-1 options we track. There's also a month-to-month option for people who don't want to prepay a quarter up front, but it costs noticeably more per month — you're paying a premium for flexibility. Tirzepatide follows the same structure at a higher tier. Both prices include the medication and free expedited shipping, so the headline figure is closer to your true out-of-pocket than at providers who tack on separate shipping or visit fees.

• Lowest cost comes from the longer bundle — the month-to-month rate is meaningfully higher
• Same price at every dose, so titrating up the ladder never raises your bill
• Medication and expedited shipping included in the quoted price
• No brand-name option — this is compounded semaglutide and tirzepatide only

The medications, and how care is delivered

You're choosing between two compounded molecules: semaglutide (the compound behind Ozempic and Wegovy) and tirzepatide (the compound behind Mounjaro and Zepbound). Cielo doesn't offer the FDA-approved branded pens, and it doesn't pretend to. That keeps the price down but means you're relying on a compounding pharmacy rather than a manufacturer's sealed product.

Clinical care isn't delivered by Cielo itself. By its own terms, 'Cielo Health' is not a medical practice — it's a platform contracted with MD Integrations, a third-party clinician network that many telehealth brands share. A licensed clinician reviews your intake and, if appropriate, writes the prescription. This is a common and legitimate structure, but it's worth understanding: the brand you're signing up with and the people making your medical decisions are separate organizations.

What sets Cielo apart

Two things make Cielo distinct. First, the radical focus — by refusing every adjacent product category, it can compete almost entirely on price and simplicity, and it does. Second, the flat-dose pricing genuinely removes a real source of bill-creep that frustrates patients at dose-tiered providers. It's also more transparent about its corporate identity than many budget compounders: it publishes a real St. Petersburg, Florida corporate address and a working customer-service phone line, which is more than some rivals manage.

Where Cielo falls short

This is a lean operation, and the gaps show. There's no LegitScript certification, no NABP .pharmacy seal, and no HIPAA badge displayed on the site — the trust signals we like to see on a platform handling prescriptions and health data. The actual compounding pharmacy is never named; you're told only that it uses 'regulated FDA pharmacy partners.' The list of states where Cielo operates isn't published anywhere we could find, so you can't confirm coverage in your state before signing up. And we noticed a small but telling inconsistency: a donation page shows zero percent next to a claimed ten-percent pledge. None of these is automatically disqualifying, but together they explain why our verification confidence here is medium rather than high.

Who should choose it — and who should skip it

Choose Cielo if you're a price-sensitive, self-directed patient who already knows you want compounded semaglutide or tirzepatide, is comfortable prepaying a multi-month bundle to hit the lowest rate, and doesn't need brand-name medication or a long list of accreditation badges to feel comfortable.

Skip it if you want the FDA-approved branded pens, if seeing a named pharmacy and visible certifications is non-negotiable for you, if you need to confirm state availability before paying, or if you want a more high-touch coaching relationship rather than a transactional fill-and-ship service.

The bottom line

Cielo is a no-frills, price-led entry into compounded GLP-1 therapy. The flat per-dose pricing and free shipping make the $115-a-month bundle one of the better headline deals in the category, and the focus on a single job is refreshing. But you're trading away transparency: an unnamed pharmacy, missing accreditation badges, and an undisclosed state list mean you should do your own diligence before handing over payment. For a budget-minded patient who knows exactly what they want, it's a reasonable pick — just go in with eyes open, and see our scoring methodology for how we weigh price against trust signals like these.

Shopping around? PeterMD ($105/month) and Try Ageless ($119/month) are the nearest alternatives to Cielo in our rankings.